Mark Your Calendar to Join Us Next Year September 23-26, 2024
Hynes Convention Center in BostonBoston, MA Mark DuerkopChief Executive Officer at Novasign
Profile
Dr. Mark Duerkop is co-founder and CEO of Novasign GmbH a spin-off from the University of Natural Resources and Life Sciences in Vienna focusing on accelerating bioprocess development by application of advanced machine learning tools. Within the last years Mark developed a hybrid modeling software with his team that help bioprocess engineers to better understand their processes while additionally reducing the experimental effort to find process optima.
Agenda Sessions
The Future of Digital Bioprocess Development and Manufacturing. Guideline For the Successful Implementation of Digital Twins To Maximize Process Understanding To Ultimately Enable Fully Automated Process Control
, 4:00pmView SessionChairperson’s Opening Remarks
, 7:55amView Session